Huai'an First People's Hospital
A Prospective, Single Arm, Open Label, Phase II Clinical Study on the Efficacy and Safety of Ivonescimab (AK112) Combined With TAS-102 in the Treatment of Refractory MSS/pMMR Advanced Colorectal Cancer
- Conditions
- MSS/pMMR Type Metastatic Colorectal Adenocarcinoma Patients
- Interventions
- Drug: Ivonescimab,TAS-102
- First Posted Date
- 2025-04-20
- Last Posted Date
- 2025-04-20
- Lead Sponsor
- Huai'an First People's Hospital
- Target Recruit Count
- 35
- Registration Number
- NCT06936488
- Locations
- 🇨🇳
The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University#Huai'an First People's Hospital#, Huai'an,, Jiangsu, China
Oxygen Study-Orelabrutinib Combined With Obinutuzumab(O2) for First-Line Treatment of Marginal Zone Lymphoma
- First Posted Date
- 2024-08-22
- Last Posted Date
- 2024-08-22
- Lead Sponsor
- Huai'an First People's Hospital
- Target Recruit Count
- 51
- Registration Number
- NCT06566807
- Locations
- 🇨🇳
The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University#Huai'an First People's Hospital#, Huai'an,, Jiangsu, China
A Clinical Study Evaluating the Safety and Efficacy of ZRMT Regimen in the Treatment of PCNSL
- Conditions
- Primary Central Nervous System Lymphoma
- Interventions
- First Posted Date
- 2024-06-06
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- Huai'an First People's Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06445257
- Locations
- 🇨🇳
The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University（Huai'an First People's Hospital）, Huai'an, Jiangsu, China
Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA.
- Conditions
- Acute Myeloid Leukemia
- Interventions
- First Posted Date
- 2024-03-25
- Last Posted Date
- 2024-03-25
- Lead Sponsor
- Huai'an First People's Hospital
- Target Recruit Count
- 34
- Registration Number
- NCT06328179
- Locations
- 🇨🇳
The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University（Huai'an First People's Hospital）, Huai'an, Jiangsu, China
Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma
- Conditions
- Esophageal Squamous Cell Carcinoma
- Interventions
- Radiation: radiotherapy
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2024-01-09
- Lead Sponsor
- Huai'an First People's Hospital
- Target Recruit Count
- 434
- Registration Number
- NCT03600831
- Locations
- 🇨🇳
Huai'an second peiple's Hospital, Huai'an, Jiangsu, China
🇨🇳Lianshui County Peoples Hospital, Huai'an, Jiangsu, China
🇨🇳xuyi peiple's Hospital, Xu Yi, Jiangsu, China
Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of Esophagus
- First Posted Date
- 2018-07-13
- Last Posted Date
- 2021-04-06
- Lead Sponsor
- Huai'an First People's Hospital
- Target Recruit Count
- 32
- Registration Number
- NCT03585530
- Locations
- 🇨🇳
Huai'an First Hospital, Huai'an, Jiangsu, China
Study of Apatinib in Metastatic Esophageal Cancer
- First Posted Date
- 2016-02-17
- Last Posted Date
- 2016-02-17
- Lead Sponsor
- Huai'an First People's Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT02683655
- Locations
- 🇨🇳
Huaian First People's Hospital, Huaian, Jiangsu, China